RE: Future trials29 Sep 2022 14:47
Good post.
Rather than a dilution, I'd prefer a collaboration with a large Pharma where they pay for the trial but maybe take half the income from future sales.
The involvement of a BP in the creation and implementation of a trial fills me with more confidence than if Synairgen did it on its own given its past performance of running their own trials.
Also, a BP will have the political clout that this drug needs to reach commericialisation.
I am now considering using this investment as a tax write-off against future Captital Gains.
You can sense this is ****** now.
We have 12 months possibly less. The team at Synairgen have, so far, squandered a once in a 100 year opportunity.
Rest assured though in the next AGM they will be VERY smooth. Why? They've had a lot of practice of handling disgruntled investors over the years.
Tax-write off it is.